(Untreated cells are denoted at 0 hr and served as the control.) E‐treated cells were the only group to demonstrate an increasing trend with time for IGF‐1 levels, as seen in Figure 5 a.
← all excerpts
Hormone replacement therapy attenuates hearing loss: Mechanisms involving estrogen and the IGF-1 pathway.
1
—
—